Chemical Abortion Risk Awareness Act
Sponsor

Full profile: /officials/S001188
Source: Congress.gov · FEC
Cosponsors (1)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Plain-English Summary
This bill would require doctors to inform patients about the risks associated with medication-based abortion before providing the drugs, and would establish reporting requirements for any serious complications that occur. The measure would affect women seeking abortion care and healthcare providers who administer these medications. Supporters argue it increases informed consent, while opponents contend it could create barriers to accessing abortion services.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR8278Fostering the Use of Technology to Uphold Regulatory Effectiveness in Supervision ActReferred to Committee · 2026-06-24
- HRES1339Expressing the sense of the House of Representatives in support of Prime Minister Benjamin Netanyahu's initiative to transition the United States-Israel relationship toward mutual defense cooperation and joint economic investment, recognizing the contributions of Israel to joint military operations against Iran, and condemning the global rise of antisemitism.Referred to Committee · 2026-06-03
- HR8155Foreign Propaganda Transparency ActReferred to Committee · 2026-03-27
- HR8090To require the Federal Deposit Insurance Corporation and the National Credit Union Administration to carry out an analysis to determine whether insurance coverage should be raised on covered transaction accounts, and for other purposes.Referred to Committee · 2026-03-25